This pilot study shows that CD40/ CD40L pathway up-regulation in MDD patients relates increased levels of sCD40L to a prothrombotic state and, preliminarily, indicates that SSRI therapy may significantly reduce sCD40L and CD40L levels associated with proinflammatory and prothrombotic states.
No takes yet. Share an insight, caveat, or question.
Leo et al. (2006) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: